文献速递疼痛医学术前评估与围术期医学

硬膜外镇痛、连续手术部位镇痛与患者自控吗啡在开放性肾切除术后镇痛效果比较

Effectiveness of Epidural Analgesia, Continuous Surgical Site Analgesia, and Patient-Controlled Analgesic Morphine for Postoperative Pain Management and Hyperalgesia, Rehabilitation, and Health-Related Quality of Life After Open Nephrectomy: A Prospective, Randomized, Controlled Study.
PubMed 文献 · Anesth Analg · 2017-01-01

EA和CSSA组24小时静息及咳嗽疼痛评分更低,吗啡消耗更少,康复更快,痛觉过敏面积更小;CSSA还减轻术后1个月残余痛并优化3个月生活质量。

要点

  • EA和CSSA均显著改善开放性肾切除术后镇痛并减少吗啡消耗。
  • EA和CSSA加速术后康复并缩小伤口痛觉过敏面积。
  • CSSA可减轻术后1个月残余痛并改善3个月生活质量。

核心结论

  • CSSA和EA显著改善开放性肾切除术后镇痛,减少吗啡消耗和伤口痛觉过敏面积,加速康复。
  • CSSA显著减轻术后1个月残余痛严重程度并优化术后3个月生活质量参数。

研究设计与样本

  • 所有患者必要时均接受患者自控吗啡;主要结局为24小时疼痛评分。

主要发现

  • 24小时静息疼痛均值±标准差:EA组2.4±1.7,CSSA组2.2±1.2,对照组4.2±1.2,P<.001;咳嗽时EA和CSSA组疼痛更低。
  • 对照组总吗啡消耗量更高;EA和CSSA组康复参数改善更早。
  • 48小时痛觉过敏面积中位数EA组36.4 cm、对照组52 cm,P=.01;72小时EA组40 cm、CSSA组39.5 cm、对照组59 cm,P=.002。
  • CSSA减轻术后1个月疼痛和痛觉过敏严重程度,并优化术后3个月生活质量(角色生理评分P=.005)。

临床怎么用

  • 开放性肾切除术后可优先考虑EA或CSSA以改善镇痛、减少阿片消耗并加速康复。
  • 关注CSSA对术后1个月残余痛和3个月生活质量的潜在获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is no widely recognized effective technique to optimally reduce pain scores and prevent persistent postoperative pain after nephrectomy. We compared continuous surgical site analgesia (CSSA), epidural analgesia (EA), and a control group (patient-controlled analgesic morphine) in patients undergoing open nephrectomy. METHODS: Sixty consecutive patients were randomized to be part of EA, CSSA, or control groups postoperatively for 72 hours. All patients received patient-controlled analgesic morphine, if needed. Hyperalgesia was assessed on the first, second, and third postoperative days. Chronic pain characteristics and quality of life were analyzed at 1 and 3 months. The primary outcome was the pain score at 24 hours. Secondary outcomes were morphine consumption, postoperative rehabilitation, hyperalgesia, chronic pain incidence, and quality-of-life parameters. RESULTS: At 24 hours, mean ± standard deviation pain values at rest (2.4 ± 1.7, 2.2 ± 1.2, and 4.2 ± 1.2, respectively, in EA, CSSA, and control groups, P <.001) and during coughing was lower in the EA and CSSA groups. Total morphine consumption was higher in the control group. Rehabilitation parameters improved sooner in the EA and CSSA groups. Median values of area of hyperalgesia differed at 48 hours between the EA group and the control group (36.4 cm) and (52 cm) (P = .01) and at 72 hours among the EA group, CSSA group, and the control group (40 cm, 39.5 cm, and 59 cm, respectively; P = .002). CSSA reduced the severity of pain and hyperalgesia at 1 month and optimized quality of life 3 months after surgery (role physical scores, P = .005). CONCLUSIONS: CSSA and EA significantly improve postoperative analgesia, reduce postoperative morphine consumption, area of wound hyperalgesia, and accelerate patient rehabilitation after open nephrectomy. CSSA significantly reduces the severity of residual pain 1 month after surgery and optimizes quality-of-life parameters 3 months after surgery.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Capdevila X, Moulard S, Plasse C, et al. Effectiveness of Epidural Analgesia, Continuous Surgical Site Analgesia, and Patient-Controlled Analgesic Morphine for Postoperative Pain Management and Hyperalgesia, Rehabilitation, and Health-Related Quality of Life After Open Nephrectomy: A Prospective, Randomized, Controlled Study. Anesth Analg. 2017. PMID: 27918333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。